ELK Biotechnology

What ELK Biotechnology does

ELK Biotechnology (legal name: ELK Biotechnology CO., Ltd.) is a privately held life sciences reagent manufacturer founded in 2018 and headquartered in Wuhan, China, with a US sales office in Sugar Land, Texas. The company produces research-grade biological reagents across five integrated product categories: ELISA kits (precoated, easy-step, high sensitivity, and microsample formats across 20+ species, with a catalog exceeding 9,000 SKUs), antibodies (monoclonal, polyclonal, secondary, and tag antibodies, with a catalog exceeding 11,000 SKUs), molecular biology reagents (nucleic acid purification kits, qPCR/RT-PCR reagents, cloning systems, DNA standards, and specialty kits such as a Nipah virus detection kit), recombinant proteins, and cell and biochemical assay kits. ELK serves global research institutions, biotechnology and pharmaceutical companies, and academic and educational customers with products that have been cited in peer-reviewed publications in Cell, Signal Transduction and Targeted Therapy, ACS Nano, Bioactive Materials, and Advanced Science. Quality systems are anchored by ISO9001 certification and CE marking on core products, and the company was awarded the CiteAb 'ELISA Kit Supplier to Watch' recognition in 2026.

The company's R&D and production operations are consolidated in a 6,000-square-meter facility in the Wuhan East Lake High-Tech Development Zone, organized around five core technology platforms: morphological pathology, cell biology, molecular biology, protein immunology, and model animal technology (the last supported by SPF-grade animal facilities and independent cell culture rooms). The technical team is led by 30+ masters- and PhD-level researchers, and total headcount is 51-100. The firm is founder-controlled and CEO-led by Mr. Xia, with no external institutional funding disclosed.

ELK operates a hybrid distribution model combining (1) a China domestic distributor network covering all 32 provinces, autonomous regions, and municipalities, (2) an international distributor network spanning 80+ countries (with named partners in the UK, US, Germany, India, Israel, Iraq, and Taiwan), (3) a direct US sales office in Sugar Land, TX, and (4) an e-commerce storefront at elkbiotech.com. Revenue is generated through one-time unit purchases with tiered volume discounts (typical pricing $6-$1,400 per SKU depending on format and volume); there are no subscription, licensing, or recurring revenue streams disclosed. Cumulative end-clients exceed 8,000 across the global footprint.

Name

ELK Biotechnology

Legal name

ELK Biotechnology CO.,Ltd.

Website

https://elkbiotech.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

ELK Biotechnology is a Wuhan, China-based life sciences reagent manufacturer producing ELISA kits, antibodies, molecular biology reagents, recombinant proteins, and assay kits for global research institutions, pharmaceutical and biotechnology companies, and academic customers across 80+ countries.

Ownership category

akta.pro rank

Product category

Life Science Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Life science reagents
• ELISA kits
• Antibody products
• Molecular biology reagents
• Recombinant proteins

Headquarters

HQ city

Denver

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Revenue model

1. ELISA Kits Sales: Sale of ELISA kits including precoated, easy step, high sensitivity, and microsample variants across over 20 species. Core flagship product category.
2. Antibodies Sales: Sale of monoclonal, polyclonal, and secondary antibodies as well as internal control/tag antibodies. Product catalog exceeds 11,000 antibodies.
3. Molecular Biology Reagents Sales: Sale of molecular biology reagents including nucleic acid purification kits, qPCR/RT-PCR reagents, cloning systems, DNA molecular weight standards, and Nipah virus detection kits. Portfolio includes over 70 reagent types.
4. Recombinant Proteins Sales: Sale of recombinant proteins for research applications.
5. Biochemical Assay Kits Sales: Sale of cell assay kits and biochemical assay kits for research use.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

ELK Biotechnology designs, manufactures, and sells research-grade biological reagents used by life science laboratories worldwide. Its core catalog spans antibodies (monoclonal, polyclonal, secondary, and tag antibodies), ELISA kits, molecular biology reagents, recombinant proteins, and biochemical assay kits. Production leverages SPF-grade animal facilities and is operated under an ISO 9001 quality system, with CE-marked finished products distributed to academic, biotech, pharmaceutical, and clinical research customers.

Product overview

ELK Biotechnology is an integrated global reagent supplier engaged in R&D, production, and marketing of life science research tools. The company offers a comprehensive portfolio organized into five main product categories: (1) Antibodies including Monoclonal, Polyclonal, and Secondary Antibodies plus Tag Antibodies; (2) ELISA Kits featuring Precoated, Easy Step, High Sensitivity, and Microsample formats across multiple species; (3) Molecular Products encompassing Nucleic Acid Purification kits (plant, bacterial, stool, viral), qPCR/RT-PCR reagents (SYBR Green mixes, cDNA synthesis kits), Cloning Systems, and DNA standards; (4) Biochemical Assays including Cell Viability and biochemical assay kits; and (5) Recombinant Proteins. The product portfolio spans over 9,000+ ELISA kits and 11,000+ antibodies, covering more than 20 species and serving diverse research applications in immunology, molecular biology, cell biology, and pathology. The company operates from a 6,000+ square meter facility with five technology platforms (morphological pathology, cell biology, molecular biology, protein immunology, and model animal technology) and distributes products to over 80 countries globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibodies

Quantifiable outcome

• Products cited in high-impact publications including journals with Impact Factor 52.7 (Signal Transduction and Targeted Therapy), 42.5 (Cell), 20.3 (Bioactive Materials), 16.1 (ACS Nano), and 14.3 (Advanced Science)
• +1 more outcomes

Named customers8 records

Segments4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and major.

• Level Biotechnology Inc. (Taiwan)coreChannel Partner/ Reseller/ Distributor · 19 December 2025Level Biotechnology Inc., established in 1989 and a renowned biotechnology enterprise in Taiwan, entered into a cooperation agreement with ELK Biotechnology in December 2025. Vice President Edward Ye visited ELK's Wuhan facility and toured the laboratory spanning floors 4-11. Both companies share highly consistent philosophies in emphasizing product quality, technological innovation, and commitment to scientific research. Discussions focused on resource sharing, technological complementarity, and market synergy.
• Universal Biotechnology (India)coreChannel Partner/ Reseller/ Distributor · 15 December 2025Represented by Deepak from India, Universal Biotechnology conducted its second visit to ELK's newly completed 6,000-square-meter laboratory in December 2025. Both parties engaged in in-depth discussions regarding sales plans and growth strategies for 2026. Deepak expressed confidence in future cooperation and intent for deeper collaboration after witnessing ELK's rapid development and advanced facilities.
• Pivotal Scientific (UK)majorChannel Partner/ Reseller/ Distributor · 15 October 2025Tim from Pivotal Scientific was among the first group of international visitors to tour ELK's newly inaugurated 6,000 m² laboratory facility in October 2025. Representatives from several globally renowned enterprises participated in the landmark visit, exchanging ideas on penetrating local markets and strengthening strategic cooperation.
• 2BScientific (UK)majorChannel Partner/ Reseller/ Distributor · 15 October 2025Will from 2BScientific (UK) was among the first international guests to visit ELK's new laboratory in October 2025. The visit allowed clients to see significant potential for cooperation through ELK's strong R&D capabilities and comprehensive promotional support.
• ARP (USA)majorChannel Partner/ Reseller/ Distributor · 15 October 2025Dan from ARP (USA) visited ELK's new laboratory as part of the first group of international visitors in October 2025. The visit focused on strengthening strategic cooperation and market penetration discussions.
• GeneTex (Germany)majorChannel Partner/ Reseller/ Distributor · 15 October 2025Jonas from GeneTex (Germany) was among the first international guests to tour ELK's new laboratory facility in October 2025. The clients expressed strong interest in deep collaboration after observing ELK's advanced facilities and professional environment.
• Israeli Partner (Mr. Doron)majorChannel Partner/ Reseller/ Distributor · 11 August 2025Mr. Doron from Israel concluded a constructive visit to ELK Biotechnology's Wuhan facility in August 2025. Discussions focused on market penetration strategies. ELK's R&D team showcased five core platforms: Immunology, Molecular Biology, Pathology, Animal Model, and Cell Biology with live product demonstrations. Outcomes included amplified trust, elevated operational efficiency, and renewed commitment to innovation-driven collaboration.
• Iraq Biotechnology Company (Mr. Karzan)majorChannel Partner/ Reseller/ Distributor · 5 August 2025Mr. Karzan from Iraq visited ELK Biotechnology's Wuhan factory in August 2025, advancing the strategic alliance for global market expansion. ELK's sales and technical R&D team provided a technical showcase including a tour of R&D labs featuring five core platforms, product demonstrations, equipment capabilities, and QC processes, followed by discussions on biotechnology trends and joint opportunities.

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Cell Signaling Technology (CST): Premium-positioned antibody and immunoassay supplier with deep citation presence in cell signaling research; competes for the same research-customer wallet share as ELK but at a higher price point and narrower focus.
• GenScript: Larger, US-listed life science services and reagent provider with overlapping antibody, recombinant protein, and cell biology offerings, plus broader services including gene synthesis and cell therapy.

Direct peers

• Boster Biological Technology: California-anchored antibody, ELISA kit, and IHC reagent manufacturer with comparable catalog breadth and a global distributor network serving academic and biotech researchers.
• Elabscience Biotechnology: Wuhan-based, China-headquartered life science reagent manufacturer with overlapping ELISA kits, antibodies, and molecular biology reagent catalog, serving global research customers through distributor channels. Closest direct competitor given the shared product mix and geographic origin.
• Abbexa: UK-based research reagent supplier of antibodies, ELISA kits, and proteins with a global catalog, directly comparable to ELK in product mix and target customer.
• ABclonal Technology: China-headquartered antibody and molecular biology reagent company that has scaled globally, with overlapping product categories including polyclonal/monoclonal antibodies and ELISA reagents.
• Proteintech Group: Antibody-focused manufacturer with an expanded ELISA and recombinant protein portfolio, comparable to ELK's antibody leadership while serving a more established global customer base.
• Wuhan Fine Biotech (FineTest): Wuhan-based ELISA kit and antibody manufacturer with a similar catalog focus and distribution model to ELK, making it a geographically and product-overlapping direct peer.
• Biomatik: Canada-based research reagent supplier offering ELISA kits, antibodies, and recombinant proteins, overlapping with ELK's catalog and targeting similar research customer segments.
• CUSABIO: China-based manufacturer of ELISA kits, antibodies, and recombinant proteins with global distribution, overlapping closely with ELK's core catalog and customer base in research reagent markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@elkbiotechnology1645
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/elk-biotechnology

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELK Biotechnology